UCO Bank
UCOBANKUCO Bank's earnings have outrun its stock. EPS grew +13.3% in a year against a −16.8% price move.
The sharpest disagreement: annual EPS moved +13.3% against a −16.8% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (100 weeks in) while the P/BV sits at the 61st percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +8.1% year on year, and gross NPA has eased to 2.08%. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
UCO Bank trades at ₹24.1, in a downtrend and 100 weeks into that stage. That is −11.7% against its own 200-day average. It sits at 5% of a 52-week range of ₹24 to ₹33. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (7 weeks and counting).
Today the stock is in a downtrend — week 100 of stage 4, confirmed. At ₹24.1 it trades −11.7% versus its 200-day average and sits at 5% of its 52-week range (₹24–₹33).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved −23% while the NIFTY 500 moved +273% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
UCO Bank trades at 0.9× P/BV, mid-range by its own standards (61st percentile). Its long-run median P/BV is 0.7×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 0.9× is mid-range by its own standards (61st percentile), against a long-run median of 0.7× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 9% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
Why the multiple sits where it does: over the past year book value grew while the price moved −16.8% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +11.2%/yr price move, ~+2.5%/yr came from book-value growth and ~+8.7 pp from the multiple (expanding); over 10y, of the −5.6%/yr price move, ~−12.9%/yr came from book-value growth and ~+7.3 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, UCO Bank was paying for profit growth of about 5.9% a year. Today the market pays 0.9× P/BV, the 61st percentile of its own 11-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is the whole of what a buyer is backing.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
UCO Bank reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROE at 8.3% is below the 12% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +4.8% | +14.2% | +12.7% | +3.5% |
| Profit | +13.2% | +14.1% | +75.3% | — |
| EPS | +13.3% | +12.3% | +67.0% | — |
| Share price | −16.8% | −11.8% | +11.2% | −5.6% |
4-Factor Sector Score
40.6/100 — rank 12 of 13 in Banks - PSU · 100% evidence confidence
UCO Bank scores 40.6 out of 100 against the 13 companies it is compared with in Banks - PSU, ranking 12. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 16.2 + 8 + 11.7 + 4.7 = 40.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
UCO Bank reported ₹6,996 Cr of income in the Jun 26 quarter, +8.7% year on year. Over 10 years it has compounded at 3.5% a year. The last full year, FY26, came in at ₹26,281 Cr. The last four reported quarters add to ₹26,841 Cr.
FY26 revenue came in at ₹26,281 Cr (+4.8% on the year), capping 10 years at 3.5% compound. The latest quarter (Jun 26) printed ₹6,996 Cr, +8.7% year on year.
Pace check: the last four quarters averaged +5.5% growth against the decade's 3.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +5.3% over the last 4 quarters against +8.8%/yr over the last 8 — rolling over; TTM profit +12.6% vs +19.2%/yr — rolling over.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
UCO Bank's net margin is 9.4% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the net margin has ranged −31.6% to 10.5%. The current quarter sits inside that band.
The latest quarter's net margin is 9.4%, +0.0 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged −31.6%–10.5%, and FY26's 10.5% is the top of that band — a record year.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
UCO Bank earned ₹656 Cr of net profit in the Jun 26 quarter, +8.1% year on year. It is the 9th consecutive quarter of growth. Full-year FY26 profit was ₹2,768 Cr. That is 9.4% of the quarter's revenue. The same quarter a year earlier earned ₹607 Cr.
Jun 26 profit was ₹656 Cr, +8.1% year on year — the 9th consecutive quarter of growth. On the full year, FY26 printed ₹2,768 Cr (+13.2%).
Why profit moved: revenue contributed +8.7% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +12.4% vs revenue +5.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
UCO Bank's gross NPA is 2.08% of the loan book in Jun 26, down from 2.63% a year ago. Net of provisions already set aside, 0.25% remains. That is the 11th straight quarter of improvement. Across the 12 quarters held here the book has ranged 2.08% to 4.14%. Falling NPAs are a loan book healing; rising NPAs are damage arriving.
Jun 26: gross NPA at 2.08% and net NPA at 0.25%, against 2.63% / 0.45% a year ago. Over the 12 quarters we hold, the book's worst reading was 4.14% and its best is 2.08% — which is the current print. The ladder has now improved for 11 consecutive quarters.
The synthesis: profit growth at a bank is only as good as the book behind it, and this book is healing on a multi-quarter streak. A note on depth: quarterly provisioning detail is not in our numbers yet, so this ladder reads levels and trend, not the cost of the cleanup.
Why the ladder moved: recoveries, write-offs and slippages each play a part, and that split sits below what we hold — the numbers show the healing; the driver mix does not travel with them.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
UCO Bank's revenue grew +4.8% in FY26 to ₹26,281 Cr, so the book is growing. The latest quarter ran +8.7% year on year. The net margin on that income is 9.4%, +0.0 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was ₹26,281 Cr, +4.8% on the year, and the latest quarter ran +8.7% year on year. The net margin on that revenue is 9.4% this quarter (+0.0 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
UCO Bank earns a return on equity of 9% in FY26. Its trough over the ladder below was −32% in FY18. On the asset side every ₹100 of the balance sheet earned about ₹0.73, which is the return before leverage is applied.
FY26 ROE came in at 9%, recovered from a FY18 trough of −32%. On assets, the latest reading is about 0.73% — every ₹100 the bank deploys earns roughly ₹0.73 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why: the ROE ladder shows the move; the deposit-cost and provisioning drivers behind it sit below what we hold.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 4.4 points of UCO Bank over 8 quarters, the biggest move on the register. That takes promoters to 91.0% of the company. Domestic institutions moved +3.0 points over the same window, to 4.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −4.4 points over 8 quarters to 91.0%; Domestic institutions: +3.0 points over 8 quarters to 4.3%; Foreign institutions: +0.0 points over 8 quarters to 0.1%.
🚨 Why the register moved: promoters drove it (−4.4 points), absorbed on the other side by domestic institutions (+3.0 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
UCO Bank: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bank of MaharashtraMAHABANK | 77.8/100Favorable setup100% evidence | ASLEEP | 29.3/35 Income 15.8% · PAT 31% 100% evidence | 24.3/25 ROA 2% · ROE 22.6% · GNPA 1.4% 100% evidence | 10.2/20 P/BV 1.81× · P/BV÷ROE 0.08 100% evidence | 14.0/20 RS sector 23.4% · RS bench 21% · 1Y 60.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 29.3 + 24.3 + 10.2 + 14 = 77.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Indian Overseas BankIOB | 66.0/100Favorable setup87% evidence | TURNING | 31.5/35 Income 14.8% · PAT 51.8% 100% evidence | 17.0/25 ROA 1.4% · ROE 15.6% · GNPA — 72% evidence | 12.4/20 P/BV 1.64× · P/BV÷ROE 0.1 100% evidence | 5.1/20 RS sector -11.8% · RS bench -5.5% · 1Y -14.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 31.5 + 17 + 12.4 + 5.1 = 66 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11.8% and the one-year return is -14.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Indian BankINDIANB | 61.2/100Mixed-positive evidence100% evidence | FADING | 20.8/35 Income 9.5% · PAT 16.6% 100% evidence | 17.4/25 ROA 1.3% · ROE 15.4% · GNPA 1.9% 100% evidence | 9.6/20 P/BV 1.37× · P/BV÷ROE 0.09 100% evidence | 13.4/20 RS sector 3.6% · RS bench 1.4% · 1Y 28.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 17.4 + 9.6 + 13.4 = 61.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Union Bank of IndiaUNIONBANK | 59.4/100Mixed-positive evidence93% evidence | BREAKING OUT | 11.6/35 Income -1.3% · PAT 9.7% 100% evidence | 17.4/25 ROA 1.4% · ROE 15.7% · GNPA — 72% evidence | 12.4/20 P/BV 0.97× · P/BV÷ROE 0.06 100% evidence | 18.0/20 RS sector 10.2% · RS bench 7.7% · 1Y 39.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 11.6 + 17.4 + 12.4 + 18 = 59.4 · Decision use: Price leads the evidence: RS versus the benchmark is 7.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 5Punjab National BankPNB | 56.9/100Mixed-positive evidence82% evidence | BREAKING OUT | 20.1/35 Income 3.4% · PAT 32.3% 86% evidence | 12.1/25 ROA 1.1% · ROE 13% · GNPA — 72% evidence | 14.3/20 P/BV 0.86× · P/BV÷ROE 0.07 100% evidence | 10.4/20 RS sector -3.8% · RS bench 2.6% · 1Y 12.5%5 of 10 weeks ahead 70% evidence |
| Exact sum: 20.1 + 12.1 + 14.3 + 10.4 = 56.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Bank of IndiaBANKINDIA | 56.1/100Mixed-positive evidence93% evidence | ASLEEP | 22.5/35 Income 6.2% · PAT 24.1% 100% evidence | 10.2/25 ROA 1% · ROE 12.4% · GNPA — 72% evidence | 15.4/20 P/BV 0.7× · P/BV÷ROE 0.06 100% evidence | 8.0/20 RS sector 0.2% · RS bench -2% · 1Y 24.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 10.2 + 15.4 + 8 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Bank of BarodaBANKBARODA | 50.9/100Mixed-positive evidence87% evidence | ASLEEP | 9.2/35 Income 4.9% · PAT -6.3% 100% evidence | 12.8/25 ROA 1.2% · ROE 12.7% · GNPA — 72% evidence | 17.4/20 P/BV 0.73× · P/BV÷ROE 0.06 100% evidence | 11.5/20 RS sector 4.7% · RS bench -11.6% · 1Y 1.7%0 of 9 weeks ahead 70% evidence |
| Exact sum: 9.2 + 12.8 + 17.4 + 11.5 = 50.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 8Punjab & Sind BankPSB | 49.7/100Mixed-negative evidence94% evidence | BASING | 24.5/35 Income 4.6% · PAT 25.4% 100% evidence | 8.0/25 ROA 1% · ROE 9.6% · GNPA 2.2% 100% evidence | 9.8/20 P/BV 1.1× · P/BV÷ROE 0.11 70% evidence | 7.4/20 RS sector -10.1% · RS bench -11.9% · 1Y -20.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 8 + 9.8 + 7.4 = 49.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9State Bank of IndiaSBIN | 48.2/100Mixed-negative evidence84% evidence | FADING | 13.2/35 Income 5.5% · PAT 8.6% 76% evidence | 14.0/25 ROA 1.1% · ROE 15.4% · GNPA — 68% evidence | 10.5/20 P/BV 1.48× · P/BV÷ROE 0.1 100% evidence | 10.5/20 RS sector 1.5% · RS bench -0.7% · 1Y 23.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 14 + 10.5 + 10.5 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10IDBI Bank LtdIDBI | 45.0/100Mixed-negative evidence87% evidence | BREAKING OUT | 10.6/35 Income 0.9% · PAT 17.7% 100% evidence | 17.3/25 ROA 1.8% · ROE 14.1% · GNPA — 72% evidence | 12.7/20 P/BV 1.31× · P/BV÷ROE 0.09 100% evidence | 4.4/20 RS sector -30.5% · RS bench -6% · 1Y -6.1%10 of 10 weeks ahead 70% evidence |
| Exact sum: 10.6 + 17.3 + 12.7 + 4.4 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Canara BankCANBK | 44.7/100Mixed-negative evidence100% evidence | ASLEEP | 12.5/35 Income 3.1% · PAT 17.8% 100% evidence | 13.3/25 ROA 0.6% · ROE 16.1% · GNPA 1.6% 100% evidence | 14.3/20 P/BV 0.91× · P/BV÷ROE 0.06 100% evidence | 4.6/20 RS sector -6% · RS bench -8.1% · 1Y 15.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.5 + 13.3 + 14.3 + 4.6 = 44.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12UCO Bankthis pageUCOBANK | 40.6/100Mixed-negative evidence100% evidence | ASLEEP | 16.2/35 Income 5.3% · PAT 12.6% 100% evidence | 8.0/25 ROA 0.8% · ROE 8.6% · GNPA 2.1% 100% evidence | 11.7/20 P/BV 0.89× · P/BV÷ROE 0.1 100% evidence | 4.7/20 RS sector -10.2% · RS bench -12% · 1Y -15.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 8 + 11.7 + 4.7 = 40.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Central Bank of IndiaCENTRALBK | 39.6/100Mixed-negative evidence94% evidence | TURNING | 9.5/35 Income 9.4% · PAT 6.8% 100% evidence | 6.2/25 ROA 0.6% · ROE 11.9% · GNPA 2.6% 100% evidence | 18.1/20 P/BV 0.68× · P/BV÷ROE 0.06 100% evidence | 5.8/20 RS sector -9.1% · RS bench -11.5% · 1Y -12.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 9.5 + 6.2 + 18.1 + 5.8 = 39.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is UCO Bank's share price today?
UCO Bank trades at ₹24.1, −16.8% over the past year. The company is valued at ₹30,245 Cr. The stock sits at 5% of its 52-week range of ₹24–₹33, −11.7% versus its 200-day average. On the tape, the price is in a downtrend, 100 weeks in. — as of 11 September 2026.
What were UCO Bank's latest quarterly results?
UCO Bank reported total income of ₹6,996 Cr and net profit of ₹656 Cr for the Jun 26 quarter. Income rose 8.7% and profit rose 8.1% year on year. Earnings per share were ₹0.52. The net margin was 9.4%, 0.0 pp higher than a year earlier. — as of 11 September 2026.
What is UCO Bank's revenue?
UCO Bank reported revenue of ₹6,996 Cr in the Jun 26 quarter, +8.7% year on year. For the full FY26 fiscal year, revenue was ₹26,281 Cr (+4.8%). Over the last 10 years revenue compounded at 3.5% a year. — as of 11 September 2026.
What is UCO Bank's profit?
UCO Bank earned ₹656 Cr of net profit in the Jun 26 quarter, +8.1% year on year — the 9th straight quarter of growth. Full-year FY26 profit was ₹2,768 Cr. The net margin ran 9.4% in the latest quarter. — as of 11 September 2026.
What is UCO Bank's market cap?
UCO Bank's market capitalisation is ₹30,245 Cr at a share price of ₹24.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is UCO Bank's P/BV ratio?
UCO Bank trades at a P/BV of 0.9×, at the 61st percentile of its own 11-year range, against a long-run median of 0.7×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does UCO Bank pay a dividend?
Yes — UCO Bank's dividend payout was 20% of profit in FY26, and it recorded a payout in 5 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is UCO Bank overvalued?
On its own history, UCO Bank looks mid-range: its P/BV of 0.9× sits at the 61st percentile of its 11-year range (long-run median 0.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: the net margin is the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.
Is UCO Bank growing?
Yes — UCO Bank is growing: latest-quarter revenue +8.7% year on year, profit +8.1%, and the net margin +0.0 pp at 9.4%. The earnings engine currently reads: improving — as of 11 September 2026.
How is UCO Bank performing?
UCO Bank is in a downtrend, 100 weeks in. Its latest quarter's income rose 8.7% and profit rose 8.1% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is UCO Bank in?
Mixed — the growth curves are steadily positive, but ROE at 8.3% is below the 12% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +5.3% latest, profit growth +12.6% latest, eps growth +10.3% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is UCO Bank in an uptrend?
No — the price is in a downtrend (week 100 of stage 4), trading −11.7% versus its 200-day average and at 5% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is UCO Bank beating the market?
Not lately — on a trailing-13-week view UCO Bank is currently behind the NIFTY 500 (7 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved −23% against the NIFTY 500's +273% — behind the index over the full window. — as of 11 September 2026.
Will UCO Bank's share price go up?
This page publishes no price forecast for UCO Bank. What it measures instead: the share price is ₹24.1, the price is in a downtrend 100 weeks in. Its P/BV of 0.9× sits at the 61st percentile of its own 11-year range. Direction is not something this site claims to know. — as of 11 September 2026.
Who owns UCO Bank?
Promoters hold 91.0% of UCO Bank, foreign institutions 0.1%, domestic institutions 4.3% and the public 4.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 4.4 points over 8 quarters. — as of 11 September 2026.
Is UCO Bank's loan book healthy?
Gross NPA is 2.08% of UCO Bank's loan book, down from 2.63% a year ago — the 11th straight quarter of improvement, and net NPA stands at 0.25%. Falling NPAs are a loan book healing; rising NPAs are damage arriving — as of 11 September 2026.
Where is UCO Bank in its business cycle?
UCO Bank's FY26 net margin was 10.5%, against a 13-year band of −31.6%–10.5%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 9.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does UCO Bank's price assume?
At its price on 13 June 2026, UCO Bank was priced for profit growth of about 5.9% a year. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the UCO Bank story?
The sharpest disagreement: annual EPS moved +13.3% against a −16.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is UCO Bank a stock worth studying right now?
This is not investment advice. The machine read: UCO Bank's earnings have outrun its stock. EPS grew +13.3% in a year against a −16.8% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!